FDA Rule Would Allow Generics Makers To Update Labels

The U.S. Food and Drug administration on Friday proposed a major new rule that would allow generic-drug manufacturers to independently update product labels with newly discovered safety information, potentially upending recent...

Already a subscriber? Click here to view full article